KdT Ventures — 2026 Investments
1 investments dated 2026 · listed companies and verified rows first · show all
TACIT THERAPEUTICStacittx.cominMar 2026
Tacit Therapeutics develops RNA-based gene therapy approaches by redirecting cellular splicing processes to repair mutated genes.
BiotechDeep TechHealthtechSan Francisco, US
Co-investorsEisai Innovation, Inc.Laurier Startup FundMitsui Global InvestmentMichigan Capital Network
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.



